IDO1 and acute myeloid leukemia: Therefore, IDO inhibition, using novel IDO inhibitors along with chemotherapy, may be a promising approach to overcome the immune escape mechanisms in patients with AML, who exhibit increased levels of IDO expression and Tregs.